-
1
-
-
1842569206
-
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
-
Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23–30.
-
(2004)
J Clin Oncol
, vol.22
, pp. 23-30
-
-
Goldberg, RM1
Sargent, DJ2
Morton, RF3
-
2
-
-
0037531121
-
Superiority of oxaliplatin and fluorouracil–leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil–leucovorin: interim results of a phase III trial
-
Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil–leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil–leucovorin: interim results of a phase III trial. J Clin Oncol 2003;21:2059–69.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2059-2069
-
-
Rothenberg, ML1
Oza, AM2
Bigelow, RH3
-
3
-
-
2542615200
-
Oxaliplatin, fluo-rouracil, and leucovorin as adjuvant treatment for colon can-cer
-
Andre T, Boni C, Mounedji–Boudiaf L, et al. Oxaliplatin, fluo-rouracil, and leucovorin as adjuvant treatment for colon can-cer. N Engl J Med 2004;350:2343–51.
-
(2004)
N Engl J Med
, vol.350
, pp. 2343-2351
-
-
Andre, T1
Boni, C2
Mounedji–Boudiaf, L3
-
4
-
-
34250210799
-
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgi-cal adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07
-
Kuebler JP, Wieand HS, O’Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgi-cal adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198–204.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2198-2204
-
-
Kuebler, JP1
Wieand, HS2
O’Connell, MJ3
-
5
-
-
33750875793
-
Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first-and sec-ond-line treatment of advanced colorectal cancer
-
Jonker D, Rumble RB, Maroun J. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first-and sec-ond-line treatment of advanced colorectal cancer. Curr Oncol 2006;13:173–84.
-
(2006)
Curr Oncol
, vol.13
, pp. 173-184
-
-
Jonker, D1
Rumble, RB2
Maroun, J.3
-
6
-
-
85127047196
-
-
Ontario, Ministry of Health and Long-Term Care. Tor-onto: Queen’s Printer for Ontario; [Available at: cited October 24, 2007]
-
Ontario, Ministry of Health and Long-Term Care. Informa-tion on the Committee to Evaluate Drugs/Cancer Care Ontario (CED/CCO) Joint Drug Review Process [Web page]. Tor-onto: Queen’s Printer for Ontario; 2006. [Available at: www.health.gov.on.ca/english/providers/pub/drugs/dqtc_cco/ dqtc_cco_mn.html; cited October 24, 2007]
-
(2006)
Informa-tion on the Committee to Evaluate Drugs/Cancer Care Ontario (CED/CCO) Joint Drug Review Process [Web page]
-
-
-
7
-
-
85127033019
-
-
PrEloxatin [product monograph]. Laval, QC: Sanofi–Aventis Canada; [Available online at: cited Au-gust 23, 2007]
-
PrEloxatin [product monograph]. Laval, QC: Sanofi–Aventis Canada; 2007. [Available online at: www.sanofi-aventis.ca/products/en/eloxatin.pdf; cited Au-gust 23, 2007]
-
(2007)
-
-
-
8
-
-
85127049817
-
-
Rockville, MD: FDA; [Avail-able online at: cited November 6, 2007]
-
U.S. Food and Drug Administration (FDA). Eloxatin (oxaliplatin for injection) [product label]. Rockville, MD: FDA; 2004. [Avail-able online at: www.fda.gov/cder/foi/label/2004/ 021492s004lbl.pdf; cited November 6, 2007]
-
(2004)
Eloxatin (oxaliplatin for injection) [product label]
-
-
|